QLGN   $3.21  5.59% Market Open

Qualigen Therapeutics, Inc.
Total Cash 118.69K
totalCashPerShare 0.488
EBITDA -8.33M
Total Debt 1.67M
quickRatio 0.025
currentRatio 0.111
Total Revenue
debtToEquity
Revenue/Share
ROA -0.75073
ROE
grossProfits
freeCashflow -4.66M
operatingCashflow -7.00M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 2.79M
forwardPE
floatShares 242.92K
sharesOutstanding 737.00K
sharesShort 2.20K
sharesShortPriorMonth 5.51K
dateShortInterest
sharesPercentSharesOut 0.00%
heldPercentInsiders 0.05%
heldPercentInstitutions 0.01%
Short Ratio help_outline 0.72%
shortPercentOfFloat 0.00%
impliedSharesOutstanding
bookValue -22.248
Price To Book help_outline
earningsQuarterlyGrowth
netIncomeToCommon -9.27M
trailingEps -82.00%
forwardEps -1.00%
enterpriseToEbitda -0.33
lastDividendValue
lastDividendDate
currentQuarterEstimate 4Q 2023
institutionsCount 20
lastUpdated Nov. 7, 2024, 3:15 a.m.